MPP Gives 18 December Deadline For Dolutegravir Sublicense Applications
Follows November Licensing Agreement For Four Countries
The Medicines Patent Pool is giving interested parties until 18 December to submit license applications for the HIV treatment dolutegravir in four middle-income countries, following announcement of the agreement last month.
